Stock report · Delisted · Nasdaq
Wellgistics Health, Inc. Common Stock (WGRX)
3.03USD Delisted Final close · Jul 29, 2026
WGRX no longer trades. Wellgistics Health, Inc. Common Stock was delisted from the Nasdaq in July 2026.
All prices on this page are historical. The last trade was on July 29, 2026, at $3.03.
WGRX stock price history
Final trading statistics
- Final close
- $3.03
- Final trading day
- Jul 29, 2026
- Market cap at delisting
- $157.43M
- Shares outstanding
- 51.96M
- Final 52-week range
- $0.07 – $4.49
- Avg. volume (final 3 mo.)
- 564,220
- All-time high
- $248.00 · Mar 2025
- All-time low
- $2.65 · Jul 2026
- Return since IPO
- -98.4%
- Beta
- —
- Book value / share
- −$0.12
- Price / book
- -24.63
About Wellgistics Health, Inc. Common Stock
Wellgistics Health, Inc. was a U.S. wholesaler and distributor of branded and generic drugs, plus over-the-counter health and consumer products, serving drug makers and independent retail pharmacies.
It provided third-party logistics, such as warehousing, inventory control, pick and pack and shipping, for small and mid-size drug makers. Its DelivMeds platform acted as a hub for moving prescriptions and gave back-end clinical concierge support to independent pharmacies. It also ran a retail community specialty pharmacy business.
Incorporated in 2022 and based in Tampa, Florida, it was known as Danam Health, Inc. until October 2024. The stock was delisted from the Nasdaq in July 2026, with a last trade on July 29, 2026 at $3.03.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Tampa, FL
- Employees
- —
- IPO date
- February 21, 2025
- Delisted
- July 29, 2026
Wellgistics Health, Inc. Common Stock financials before the delisting
The last 4 fiscal years Wellgistics Health, Inc. Common Stock reported as a public company, fiscal year ending December.
WGRX revenue and net income
WGRX earnings per share
WGRX annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $23.34M | −$101.3M | −$14.94 |
| FY2024 | $18.13M | −$6.9M | −$0.09 |
| FY2023 | $0.00 | −$2.9M | — |
| FY2022 | $32.78M | −$2.7M | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Wellgistics Health, Inc. Common Stock stock FAQ
What happened to Wellgistics Health, Inc. Common Stock stock?
Wellgistics Health, Inc. Common Stock was delisted from the Nasdaq in July 2026. The final close was $3.03 on July 29, 2026.
Can I still buy WGRX stock?
No. WGRX is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on July 29, 2026.
What was the last price of WGRX?
WGRX last closed at $3.03 on July 29, 2026, which valued the company at about $157.43M.
How did Wellgistics Health, Inc. Common Stock do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, Wellgistics Health, Inc. Common Stock reported revenue of $23.34M and net income of −$101.3M.
When did Wellgistics Health, Inc. Common Stock go public?
Wellgistics Health, Inc. Common Stock shares started trading on February 21, 2025.
WGRX no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.